Zobrazeno 1 - 10
of 5 817
pro vyhledávání: '"Pathological complete response"'
Autor:
Pei Zhou, Xiong Sun, Liwu Zeng, Xinyu Zeng, Gengchen Xie, Xinghua Liu, Kaixiong Tao, Peng Zhang
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Objective The efficacy of lymph node ratio (LNR) as a prognostic indicator in locally advanced gastric cancer (LAGC) patients underwent radical resection after neoadjuvant immunochemotherapy (NICT) remains to be demonstrated. The objective o
Externí odkaz:
https://doaj.org/article/3a2e7080b63e48788d9e27b10b884e79
Autor:
Gülin Alkan Şen, Esra Aydın, Murad Guliyev, Nihan Şentürk Öztaş, Ezgi Değerli, Nebi Serkan Demirci, Zeynep Hande Turna, Fuat Hulusi Demirelli
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background The HER-2 status of breast cancer (BC) has been classified as negative or positive for a long time. Given the efficacy of novel anti-HER2-targeted antibody drug conjugates (ADCs) in HER2-low BC, a distinct subgroup of HER2-low tum
Externí odkaz:
https://doaj.org/article/98931270611d484a8f3f578cc960f2b5
Publikováno v:
Сибирский онкологический журнал, Vol 23, Iss 4, Pp 186-193 (2024)
Background. Triple-negative breast cancer is the most aggressive molecular subtype among breast malignancies. Due to the high proliferative activity of tumor cells and the lack of targets for targeted therapy, neoadjuvant chemotherapy plays the main
Externí odkaz:
https://doaj.org/article/920a611075ff42979c51225667c5fd8c
Autor:
Thomas Hansen, Jonathon Hill, Gary Tincknell, Derrick Siu, Daniel Brungs, Philip Clingan, Lorraine Chantrill, Udit Nindra
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 5, Iss 6, Pp 1247-1260 (2024)
The treatment of early-stage non-small cell lung cancer (NSCLC) is becoming increasingly complex. Standard of care management for the past decade has been adjuvant chemotherapy following curative intent resection regardless of nodal status or tumour
Externí odkaz:
https://doaj.org/article/452da1eb38d6484bbf431bf85daa2605
Publikováno v:
Zhongliu Fangzhi Yanjiu, Vol 51, Iss 9, Pp 779-783 (2024)
ObjectiveTo compare the efficacy of trastuzumab plus pertuzumab (HP) combined with either nab-paclitaxel plus carboplatin or docetaxel plus carboplatin as neoadjuvant therapy for HER2-positive breast cancer in real-world clinical practice. MethodsCli
Externí odkaz:
https://doaj.org/article/0bb8f6ebb60b4cd0aed449714f47c2f7
Autor:
Song Wu, Li Bian, Haibo Wang, Shaohua Zhang, Tao Wang, Zhigang Yu, Jianbin Li, Feng Li, Kun Wang, Zefei Jiang
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background TCbHP (taxane + carboplatin + trastuzumab + pertuzumab) is the preferred neoadjuvant therapy regimen for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, no consensus exists regarding whether specif
Externí odkaz:
https://doaj.org/article/a30a3b49893548ab977d8c337f316beb
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Triple-negative breast cancer (TNBC) is highly heterogeneous, resulting in different responses to neoadjuvant chemotherapy (NAC) and prognoses among patients. This study sought to characterize the heterogeneity of TNBC on MRI and
Externí odkaz:
https://doaj.org/article/523ed13c920f4affab5ef527bbc128fe
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 16, Pp 393-402 (2024)
Yu-Xiang Deng,1,* Yu-Jie Zhao,2,* Qiao-Hong Nong,3 Hong-Mei Qiu,1 Qiao-Li Guo,1 Hui Hu1 1Department of Thyroid and Breast Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technol
Externí odkaz:
https://doaj.org/article/6ab5cc35d002468890ee60d2df341e12
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The study explored the impact of pretreatment serum albumin-to-alkaline phosphatase ratio (AAPR) and changes in tumor blood supply on pathological complete response (pCR) in breast cancer (BC) patients following neoadjuvant chemotherapy (NAC
Externí odkaz:
https://doaj.org/article/ffc8b56e76d340088069c40829a3842f
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background This study developed a nomogram model using CT-based delta-radiomics features and clinical factors to predict pathological complete response (pCR) in esophageal squamous cell carcinoma (ESCC) patients receiving neoadjuvant chemora
Externí odkaz:
https://doaj.org/article/cd5ffefaac614c7c84d678ef25c82389